Account
Inquiry
Tirzepatide is a novel dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This innovative peptide represents a significant advancement in metabolic research, particularly for type 2 diabetes studies.
The compound works through multiple mechanisms: slowing gastric emptying, reducing liver glucose production, and enhancing pancreatic insulin secretion when blood sugar levels are elevated. Research indicates potential applications in weight management studies, with demonstrated effects on appetite suppression and caloric intake reduction.
Key research applications include investigation of blood glucose control mechanisms, postprandial hyperglycemia reduction, and effects on fasting insulin/glucose levels. The compound has also shown potential in studies examining triglyceride levels and oxidative stress related to high LDL.
Our tirzepatide is supplied as white lyophilized powder with 99% purity, meeting pharmaceutical grade standards. The product is carefully stored at -20°C to maintain stability and efficacy for research purposes.
For researchers looking to get tirzepatide online, we offer high-quality material with complete documentation. The peptide's molecular weight is 4813.527g/mol (C225H348N48O68), and it shares structural similarities with semaglutide while featuring unique PEG modifications that enhance water solubility.
Important Note: This product is intended for research use only, not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.
